Dexmedetomidine Ameliorates Sleep Deprivation-Induced Depressive Behaviors in Mice

Sleep deprivation induces depressive symptoms. Dexmedetomidine is a α2-adrenoreceptor agonist and this drug possesses sedative, anxiolytic, analgesic, and anesthetic-sparing effect. In this study, the action of dexmedetomidine on sleep deprivation-induced depressive behaviors was investigated using...

Full description

Saved in:
Bibliographic Details
Published inInternational neurourology journal Vol. 22; no. Suppl 3; pp. S139 - 146
Main Authors Moon, Eun-Jin, Ko, Il-Gyu, Kim, Sung-Eun, Jin, Jun-Jang, Hwang, Lakkyong, Kim, Chang-Ju, An, Hyeonjun, Lee, Bong-Jae, Yi, Jae-Woo
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Continence Society 01.10.2018
대한배뇨장애요실금학회
Subjects
Online AccessGet full text
ISSN2093-6931
2093-4777
2093-6931
DOI10.5213/inj.1836228.114

Cover

More Information
Summary:Sleep deprivation induces depressive symptoms. Dexmedetomidine is a α2-adrenoreceptor agonist and this drug possesses sedative, anxiolytic, analgesic, and anesthetic-sparing effect. In this study, the action of dexmedetomidine on sleep deprivation-induced depressive behaviors was investigated using mice. For the inducing of sleep deprivation, the mice were placed inside a water cage containing 15 platforms and filled with water up to 1 cm below the platform surface for 7 days. One day after sleep deprivation, dexmedetomidine at the respective dosage (0.5, 1, and 2 μg/kg) was intraperitoneally treated into the mice, one time per a day during 6 days. Then, forced swimming test and tail suspension test were conducted. Immunohistochemistry for tyrosine hydroxylase (TH), 5-hydroxytryptamine (5-HT; serotonin), tryptophan hydroxylase (TPH) and western blot for D1 dopamine receptor were also performed. Sleep deprivation increased the immobility latency in the forced swimming test and tail suspension test. The expressions of TPH, 5-HT, and D1 dopamine receptor were decreased, whereas, TH expression was increased by sleep deprivation. Dexmedetomidine decreased the immobility latency and increased the expressions of TPH, 5-HT, and D1 dopamine receptor, whereas, HT expression was decreased by dexmedetomidine treatment. In our results, dexmedetomidine alleviated sleep deprivation-induced depressive behaviors by increasing 5-HT synthesis and by decreasing dopamine production with up-regulation of D1 dopamine receptor.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2093-6931
2093-4777
2093-6931
DOI:10.5213/inj.1836228.114